Sato Y, Matsuzawa H, Eguchi S
Jpn Circ J. 1982 Oct;46(10):1059-72. doi: 10.1253/jcj.46.1059.
In 10 patients following open heart surgery, adrenaline, dobutamine and dopamine were administered, and the changes in hemodynamic parameters and renal blood flow (RBF) were examined. RBF was determined by the local thermodilution method. Prior to the application of this method in clinical measurement, reliability of the method was checked using a model circuit. The correlation between the actual flow and flow obtained with this method was high (r = 0.999, p less than 0.005, n = 8). Reproducibility in repeated measurements was excellent, r = 0.997 (p less than 0.005, n = 8) in the model circuit and r = 0.985 (p less than 0.005, n = 89) in the clinical measurement. Adrenaline at rates of 0.02--0.08 microgram/kg/min showed a marked inotropic action without any significant change in RBF. With 0.04 microgram/kg/min of adrenaline, the RBF/CO (cardiac output) ratio declined significantly. We conclude that adrenaline is often effective in patients following open heart surgery, but renal vasoconstriction is the major disadvantage. After a 10-min administration of 2, 4 and 8 micrograms/kg/min of dobutamine, cardiac index (CI) and stroke volume index (SVI) showed a stepwise increase in accordance with an increase of dosage, and RBF also increased with CO. Consequently, no significant change in RBF/CO was found. Mean left atrial pressure (LAP) or mean pulmonary arterial wedge pressure (PAWP) decreased in 4 of 7 patients with 8.0 micrograms/kg/min of dobutamine. Thus, dobutamine is an excellent beta 1-adrenergic agonist with a weak alpha-action on both peripheral and renal vessels. With 2.0--2.5 micrograms/kg/min of dopamine, RBF increased by 15.5% (p less than 0.05). while no significant increase appeared in CI. With 4.0 micrograms/kg/min or more of dopamine, CI and SVI increased. With 16--20 micrograms/kg/min of dopamine, RBF increased by up to 44.8%. Significant increase of mean LAP or mean PAWP was observed with 8.0--10.0 micrograms/kg/min or more of dopamine. These findings indicate that the potential increase o LVEDP (left ventricular end-diastolic pressure) with 8--10 micrograms/kg/min or more of dopamine exerts a disadvantageous effect in patients following open heart surgery. However, the effect on the renal hemodynamics, especially with small doses of dopamine, is unique and not observed with adrenaline or dobutamine.
对10例心脏直视手术后的患者给予肾上腺素、多巴酚丁胺和多巴胺,并检测血流动力学参数和肾血流量(RBF)的变化。RBF采用局部热稀释法测定。在将该方法应用于临床测量之前,使用模型回路检查了该方法的可靠性。实际流量与该方法测得的流量之间的相关性很高(r = 0.999,p < 0.005,n = 8)。重复测量的再现性极佳,在模型回路中r = 0.997(p < 0.005,n = 8),在临床测量中r = 0.985(p < 0.005,n = 89)。以0.02 - 0.08微克/千克/分钟的速率给予肾上腺素显示出明显的正性肌力作用,而RBF无任何显著变化。给予0.04微克/千克/分钟的肾上腺素时,RBF/心输出量(CO)比值显著下降。我们得出结论,肾上腺素对心脏直视手术后的患者通常有效,但肾血管收缩是其主要缺点。给予2、4和8微克/千克/分钟的多巴酚丁胺10分钟后,心脏指数(CI)和每搏量指数(SVI)随剂量增加呈逐步上升,RBF也随CO增加。因此,未发现RBF/CO有显著变化。在7例接受8.0微克/千克/分钟多巴酚丁胺治疗的患者中,有4例平均左心房压(LAP)或平均肺动脉楔压(PAWP)下降。因此,多巴酚丁胺是一种出色的β1肾上腺素能激动剂,对周围血管和肾血管的α作用较弱。给予2.0 - 2.5微克/千克/分钟的多巴胺时,RBF增加了15.5%(p < 0.05),而CI无显著增加。给予4.0微克/千克/分钟或更高剂量的多巴胺时,CI和SVI增加。给予16 - 20微克/千克/分钟的多巴胺时,RBF增加高达44.8%。给予8.0 - 10.0微克/千克/分钟或更高剂量的多巴胺时,观察到平均LAP或平均PAWP显著增加。这些发现表明,给予8 - 10微克/千克/分钟或更高剂量的多巴胺可能增加左心室舒张末期压力(LVEDP),这对心脏直视手术后的患者产生不利影响。然而,其对肾血流动力学的影响,尤其是小剂量多巴胺的影响是独特 的,肾上腺素或多巴酚丁胺未观察到这种情况。